TAT-cyclo-CLLFVY Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

TAT-cyclo-CLLFVY is a selective HIF-1 dimerization inhibitor. It blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β.

TAT-cyclo-CLLFVY Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

TAT-cyclo-CLLFVY Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shenzhen Nexconn Pharmatechs Ltd	+86-755-89396905 +86-15013857715	admin@nexconn.com	China	10311	58
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19741	58
Zhejiang J&C Biological Technology Co.,Limited	+1-2135480471 +1-2135480471	sales@sarms4muscle.com	China	10473	58
Hebei Miaoyin Technology Co.,Ltd	+86-17367732028 +86-17367732028	kathy@hbyinsheng.com	China	3512	58
Zhejiang Hangyu API Co., Ltd	+8617531972939	anna@api-made.com	China	2943	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52924	58
Changsha MOL Changes Biotechnology Co., Ltd.	+8619375158599	info@molchanges.com	China	5223	58
Creative Peptides		info@creative-peptides.com	United States	6083	56
Hangzhou Peptidego Biotech Co.,Ltd.	0571-87213919	Eric@peptidego.com	China	6958	58
Shanghai Hongye Biotechnology Co. Ltd	400-9205774	sales@glpbio.cn	China	6777	58

---

• CGRKKRRQRRRPPQ
• TAT-cyclo-CLLFVY
• cyclo(CLLFVY) (Disulfide bridge:Cys1-Cys1')
• TAT-cyclo-CLLFVY TFA
• 1446322-66-2
• C111H188N42O24S2